Randomized phase III study of first-line treatment of advanced follicular lymphoma in elderly patients (> 65 years) and younger patients who do not qualify for high-dose therapy with autologous peripheral blood stem cell transplantation, followed by an induction of immune chemotherapy by maintenance therapy with rituximab versus observation (working title : first-line treatment of advanced FL with induction chemotherapy followed by immune by maintenance therapy with rituximab versus observation).
Phase of Trial: Phase III
Latest Information Update: 29 Oct 2012
At a glance
- Drugs Rituximab (Primary) ; Chlorambucil; Cyclophosphamide; Doxorubicin; Mitoxantrone; Prednisone; Vincristine
- Indications Follicular lymphoma
- Focus Therapeutic Use
- 29 Oct 2012 New trial record